Week In Review: Zai Lab Raises $750 Million In Private Placement For In-Licensed/Novel Drugs

Company News

  • Shanghai's PhageLux, an antimicrobial company, announced its agricultural division, PhageLux AgriHealth, has acquired a new manufacturing facility in Yixing, Wuxi (see story). The company plans to spend the rest of 2021 renovating the plant. When finished, it will include a 1000 square meter research lab with pilot scale GMP manufacturing for new veterinary drugs. and 2000 square meters to produce feed additives (powder) and animal health products (liquid). The company's human health division uses bacteriophages, lyases, and new drug delivery systems to create novel therapies for patients with skin diseases. 
1 2 3
View single page >> |

Disclosure: None

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.